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1. Introduction 
The vascular endothelium is a specific organ consisting of the endothelial cell (EC) 
monolayer, weighting about 1 kg which makes a unique border between the circulating 
blood and the underlying tissues. Because of its strategic location, the endothelium interacts 
with cellular and neurohumoral mediators, thus controlling the vascular contractile state 
and cellular composition. Endothelial cells (ECs) used to be considered a layer of ”nucleated 
cellophane“, an inert lining to blood vessels, endowed with negative properties, and the 
most important of which is its ability to act as a non-thrombogenic substrate for blood. 
Further, the endothelium was thought to participate in tissue reactions as target for 
injurious agents. Now the endothelium is recognized as a semipermeable barrier that 
regulates the transfer of small and large molecules, a highly specialized, metabolically active 
organ having vital metabolic, secretory, synthetic and immunologic functions. It performs 
significant autocrine, paracrine and endocrine actions and exerts influences on smooth 
muscle cells, platelets and peripheral leucocytes. Therefore, haemostasis, inflammatory 
reactions and immunity involve close interactions between immunocompetent cells and 
vascular endothelium. 
ECs arise from hemangioblasts, blast-like bipotential cells (Choi et al., 1998). They can also 
transdifferentiate into mesenchymal cells and intimal smooth muscle cells. It is known that 
there is a marked phenotypic variation between ECs in different parts of the vascular 
system. The cells from different location in the same person not only express different 
surface antigens and receptors, but can generate different responses to the same stimulus. 
Further, cells from the same part of the vasculature can have varied responses (Galley & 
Webster, 2004).  
The vascular endothelium senses mechanical stimuli, such as pressure and shear stress, and 
hormonal stimuli, such as vasoactive substances. In respons, it releases agents that regulate 
vasomotor function, trigger inflammatory processes and affect hemostasis. Among the 
vasodilatory substances the endothelium produces are nitric oxide (NO), prostacyclin, 
different endothelium derived hyperpolarizing factors and C-type natriuretic peptide. 
Vasoconstricting molecules include endothelin-1 (ET-1), angiotensin II (Ang II), 
thromboxane A2 and reactive oxygen species (ROS) (Endemann & Schiffrin, 2004). 
Inflammatory modulators include NO, intercellular adhesion molecule-1 (ICAM-1), vascular 
adhesion molecule-1 (VCAM-1), E-selectin, and NF-κB. The endothelium realizes the 
modulation of hemostasis by releasing: plasminogen activator, tissue factor inhibitor, von 
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Willebrand factor, NO, prostacyclin, thromboxane A2, plasminogen/activator, inhibitor/1 
and fibrinogen. The endothelium also contributes to mitogenesis, angiogenesis, vascular 
permeability and fluid balance. The endothelium is indispensable for body homeostasis. An 
controlled endothelium cell response is involved in many disease processes including 
atherosclerosis, hypertension, pulmonary hypertension, sepsis and inflammatory 
syndromes including vasculitis. These diseases are related to endothelial injury, dysfunction 
and activation. 
2. Physiological functions of endothelial cell 
In order for ECs to perform their physiological functions, they should exist in the so-called 
resting or quiescent state. It seems that, under normal resting conditions, ECs constitutively 
express certain ”protective“ genes, such as that encoding Bcl-xL, the purpose of which is to 
maintain ECs in their quiescent phenotype by inhibiting nuclear factor κB (NFκB) activation 
and exerting anti-apoptotic functions (Bach et al., 1997). In this state ECs can perform their 
normal barrier and anticoagulant functions even in the presence of low levels of stimulans, 
such as shear stress, circulating endotoxins or reactive oxygen species. In the quiescent state, 
the antithrombotic, anti-inflammatory and antiproliferative properties of the endothelium 
are maintained by the dominance of nitric oxide (NO) signaling and the formation of S-NO 
modifications of proteins, shear stress signaling through the surface glycocalyx and 
signaling between pericytes and the endothelium.  
2.1 Transport functions 
ECs makes an important barrier to the free passage of molecules and cells from the blood to 
the underlying interstitium and cells. Transport functions are realized by protein 
transporters, caveolae and tight junctions. Specific transport mechanisms transport essential 
circulating macromolecules across ECs to the subendothelial space to enable the metabolic 
needs of the surrounding tissue cells. ECs express glucose transporters GLUT-1 and GLUT-
4. GLUT-1 is the most abundant endothelial isoform. The blood-brain barrier is the major 
endothelial tissue expressing GLUT transporters, although these transporters have been also 
detected in other ECs including the umbilical vein, adrenal capillaries, aorta, retina, heart, 
placenta, the eye and testis (Mann et al., 2003). 
Aminoacids are transported by multiple transport systems in ECs, but the system y+ catonic 
amino acid transporter is perhaps most relevant, since this system transports L-arginine, the 
substrate for nitric oxide. Cytokines such as TNF can stimulate L-arginine transport in ECs 
resulting in increased NO production (Bogle et al., 1995).  
Transcellular transport in ECs occurs via caveolae which represent invaginations in the cell 
membrane and which are primary important in albumin transport across the endothelium. 
Albumin binding proteins (albumin binding glycoprotein, gp60) initiate the endocytosis of 
albumin by associating with the scaffolding protein caveolin-1 and activating the kinase Src. 
The Src enzyme phosphorylates caveolin-1 and a second protein dynamin (Galley & 
Webster, 2004). This results in the fission of caveolae and internalization of albumin. In the 
endothelium, caveolin-1 regulates nitric oxide signaling by binding to and maintaining 
endothelial nitric oxide synthase (NOS) in an inactive state (Bucci et al., 2000). Caveolin-1 is 
also an important determinant of calcium signaling in ECs because calcium influx channels 
and pumps are localized in caveolae (Fujimoto, 1993). 
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Paracellular transport is realized through tight junctions. Within multicellular organisms, 
several organs are relatively independent of whole body homeostasis and are wrapped by 
EC sheets. For example, the blood brain barrier is made of highly specialized ECs whose 
tight junctions protect the central nervous system. Tight junctions can function as either a 
„gate“ (selected passage of molecules) or a „fence“ (no passage) (Sawada et al., 2003). The 
gate function regulates the passage of ions, water and various macromolecules, even of 
cancer cells, through paracellular spaces. This type of function is important in oedema, 
jaundice, diarrhoea and blood-borne metastasis. The fence function maintains cell polarity 
by preventing the mixing of molecules in the apical EC membrane with those in the lateral 
membrane. Some pathogenic bacteria and viruses target and affect the tight junction 
function, leading to diseases affecting the vascular system (oedema), the gastrointestinal 
tract (bacterial enteritides) and respiratory tract (acute respiratory distress syndrome) 
(Galley & Webster, 2004). 
2.2 Vascular tone regulation 
The endothelium produces a number of vasodilator and vasoconstrictor substances which 
regulate vasomotor tone, but the most important is NO. 
2.2.1 Nitric oxide 
Nitric oxide is the most powerful vasodilator. Resting ECs constitutively express an 
endothelial specific isoform of nitric oxide synthase (eNOS, NOS3) which synthesizes NO 
from L-arginine (Palmer et al., 1988) maintaing the vasculature in a state of vasodilatation. 
The most important stimuli are physical factors such as shear stress and pulsatil stretching 
of the vessel wall as well as circulating and locally released vasoactive substances. The 
endothelium can be taken as a biosensor reacting to a large variety of stimuli and therefore 
maintaing an adequate NO release. ECs can express both, Ca-dependent constitutive NOS 
and Ca2+-independent inducible NOS (iNOS, NOS2). In unstimulated ECs, eNOS is targeted 
to specific microdomains in the plasma membrane called caveolae, where eNOS is 
associated with a scaffold protein caveolin, resulting in the tonic inhibition of the enzyme 
activity (Garcia-Cardena et al., 1997; Michel et al., 1997). The elevation of Ca2+ induced by 
Ca2+-elevating agonists stimulates the binding of calmodulin to eNOS challenging the 
dissociation of the enzyme from caveolin and thereby its activation (Michel et al., 1997). 
Some stimuli such as shear stress and ceramide can induce the Ca2+-independent activation 
of eNOS (Igarashi et al., 1999). Shear stress and receptor agonists (such as bradykinin and 
vascular endothelial growth factor) can induce the phosphorylation of eNOS by Akt and its 
translocation to the cytosol where it interacts with calmodulin and the chaperone Hsp90. 
There is evidence that the some situations are associated  with an increased activity  and the 
amount of constitutive eNOS indicating that this isoform can also be induced. Although 
caveolae play an integral part in regulating the activity of eNOS, proinflammatory cytokines 
also increase the activity of GTP-cyclohydrolase, the rate-limiting enzyme for tetra-
hydrobiopterin production, which is a cofactor for NOS (Harrison, 1997). The y+ amino acid 
transporter channels are co-located with NOS on caveolae, and the recirculation of L-
arginine from L-citruline mediated by cytokines occurring in vascular ECs (Lee & Yu, 2002) 
makes substrate for NO production available . NO is subsequently produced by the enzyme 
only when the substrate L-arginine and the cofactor tetrahydrobiopterine are available. NO 
can then react with the cysteine motifs in proteins throughout ECs to make S-NO 
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modifications to these proteins (S-nitrosylation), thereby silencing multiple metabolic pro-
cesses, including apoptotic cell death regulation (Mannick, 2007) and the inhibition of 
mitochondrial oxidative phosphorylation during hypoxia or a protection against hypoxia by 
increasing the binding activity of hypoxia-inducible factor 1. S-nitrosylation of NF-κB can 
suppress inflammation (Rabelink & Luscher, 2006). L-arginine depletion occurs when it is 
diverted into alternative metabolic pathways through the redox induction of enzymes such 
as arginase and protein methyltransferases. 
Under prolonged redox signaling, eNOS itself may switch from being an enzyme that 
produces NO into the one that produces reactive oxygen species. This event is known as 
NOS “uncoupling”, and it is dependent on the lack of availability of the cofactor 
tetrahydrobiopterine, which is essential for the eNOS-dependent production of NO. The 
amount of tetrahydrobipterin can be reduced as a result of direct oxidation by ROS derived 
from another source followed by the amplification of oxidative stress or when hydrogen 
peroxide induces the inactivation of the enzymes GTP-cyclohydrolase and dihydrofolate 
reductase, which generate and regenerate tetrahydrobiopterine. When its levels are low the 
heme group in eNOS will directly yield superoxide and hydrogen peroxide (Crabtree et al., 
2009). The enzyme may reduce molecular oxygen rather than transfer electrons to L-
arginine, thereby generating superoxide. Superoxide is believed to originate from the 
oxygenase domain of the enzyme through the dissociation of a ferrous-dioxygen complex 
that is normally stabilized by tetrahydrobiopterine (Xia et al., 1998). This uncoupling 
converts eNOS into an accelerator of redox signaling followed by the production of large 
amounts of ROS inducing a proinflammatory state (Rabelink & Luscher, 2006). Several 
enzymes such as the hemoxygenase system (Ryter et al., 2006), antioxidant enzymes, 
thioredoxin reductase and glutathione reductase (Hojo et al., 2002) can scavenge ROS and 
“fine-tune” this activation cascade, to the extent that ROS exceed the antioxidative capacity 
of cellular antioxidants (Cai & Harrison, 2000). This process explains how the chronic 
activation of the endothelium or impaired activity of eNOS can lead to the endothelial 
dysfunction. 
Endothelial iNOS may be induced in both physiological and pathological conditions. 
Known physiological settings include pregnancy, treatment with oestradiol (Weiner et al 
1994), shear stress, chronic exercise or receptor agonists (such as bradykinine and vascular 
endothelial growth factor). In activated ECs iNOS can be induced producing much higher 
levels of NO then those present under physiological conditions and that is implicated in the 
pathogenesis of a wide variety of diseases involving endothelium (Djordjević et al., 2004; 
Djordjević et al., 2008). iNOS is highly regulated by cytokines, some of which promote while 
others inhibit the enzyme induction. Although there are indices suggesting that a cocktail of 
three cytokines (TNF-, IL-1 and IFN-) (Steiner et al., 1997), is neccesery for NOS inducti-
on, most data showed that NOS induction can be triggered by a mixture of two cytokines 
especially IL-1 and TNF (Mantovani et al., 1997). Transforming growth factor - (TGF-) 
reduces cytokine-induced iNOS activity by inhibiting iNOS mRNA translation and increa-
sing iNOS protein degradation, while IL-4 interferes with iNOS transcription (Bogdan et al., 
1991). The disruption of genes encoding IFN-, part of its receptor or an IFN regulatory 
factor results in a phenotypic deficiency in iNOS expression. EC produced NO may exert an 
autocrine function. It inhibits the cytokine-induced expression of adhesion molecules and 
cytokine production by ECs through inducing and stabilizing of NF-κB inhibitor (Peng et al., 
1995), thus attenuating proinflammatory responses. 
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2.2.2 NADPH oxidase 
An emerging paradigm in vascular homeostasis involves the balance between ROS-
mediated and NO-mediated signals. ROS contribute to cellular signaling, affecting almost 
all aspects of cellular function including gene expression, proliferation, migration and cell 
death. It is now clear that ROS play an important role in regulating the normal function of 
the endothelium. However, the generation of ROS both within ECs and in adjacent cells 
such as vascular smooth muscle cells, adventitial fibroblasts and inflammatory cells has a 
major role in the genesis of endothelial activation and dysfunction. The potential sources of 
superoxide in ECs include the mitochondrial electron transport chain, xanthine oxidase, 
cytochrome p450 enzymes, uncoupled NOS and NADPH oxidases. Mitochondria are both a 
source and a target for ROS. Because they are susceptible to oxidative damage it can result 
in enhanced mitochondrial ROS production (Cai & Harrison, 2000). Xanthine oxidase is 
expressed on the luminal surface of the endothelium and catalyses the conversion of 
hypoxanthine into urate in the process that generates superoxide. An increased xanthine-
oxidase-derived superoxide production is involved in endothelial dysfunction in several 
diseases.  
NADPH oxidase is considered as a rather special source of ROS generation since its  the 
primary function is the regulation of ROS production, primarily identified and characterized 
in phagocytes where it plays an essential role in host defense against microbial organisms. 
Furthermore it has become apparent that ROS production by NADPH oxidase homologues 
in non-phagocytic cells also plays an important role in the regulation of signal transduction 
via the modulation of kinase and phosphatase activities or through gene transcription 
(Finkel, 2003; Groemping & Rittinger, 2005). The phagocytic enzyme is normally quiescent, 
but becomes activated during the neutrophil oxidative burst when it generates large 
amounts of superoxide (Brandes & Kreuzer, 2005). The classical phagocytic NADPH oxidase 
is composed of two subunits, a catalytic subunit gp91phox (91 kDa glycosylated protein; 
where phox is phagocyte oxidase), and p22phox subunit forming a membrane-bound 
heterodimeric flavo-cytochrome b558. For fully enzyme activation a number of cytosolic 
regulatory subunits are required namely p67phox, p47phox, p40phox and the small GTPase Rac2 
which are translocated to and assembled with the membrane cytochrome in a highly 
regulated process (DeLeo & Quinn, 1996) that involves the post-translational modification of 
several cytosolic subunits and specific protein-protein binding through tandem SH3 (Src 
homology) domains. The tight regulation of enzymatic activity is achieved by two 
mechanisms: the separation of the oxidase subunits into different subcellular locations 
during the resting state and the modulation of reversible protein-protein and protein-lipid 
interactions. In the activated enzyme complex, the flavin-containing catalytic subunit 
functions as an electron transport system which uses NADPH as a donor of electrons that 
are transferred to molecular oxygen, resulting in the generation of superoxide.  
Initially, several homologues of the gp91phox catalytic subunit have been identified, each 
encoded by separate genes and designated Noxs. These are now seven members: Nox1, 
Nox2, Nox3, Nox4, Nox5, Duox1 and Duox2. Nox2 contains gp91phox. It seems that all the 
Nox homologues may bind to p22phox in a similar manner to the gp91phox/ p22phox complex. 
In the case of Nox1, homologues of p47phox and p67phox (NOXO1 and NOXA1) have been 
found to be important for its activation. On the other side, Nox4 activation does not require 
either p47phox and p67phox (Ray & Shah, 2005).  
ECs express all the classical NADPH oxidase subunits. However, there are a few significant 
differences between phagocytic oxidase and the enzyme in ECs. Firstly, endothelial oxidase 
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continuously generates small amounts of superoxide even in unstimulated cells, but its 
activity can be augmented by specific agonists. Secondly, a large proportion of the 
superoxide generated in ECs is intracellular, whereas neutrophil superoxide generation is 
mainly in the extracellular compartment. The Nox2 oxidase is predominantly located in a 
perinuclear distribution in association with the cytoskeleton. There are also many fully 
preassembled ROS generating oxidase complexes which can explain both the continuous 
low-level superoxide generation in unstimulated endothelium and the intracellular site of 
ROS production. The Nox4 isoform is expressed in greater amounts in ECs and seems to 
contribute to the basal constitutive superoxide generation.. Additionally, ECs express the 
Nox1 enzyme in smaller amounts than the Nox2 isoform. Endothelial NADPH oxidase may 
be stimulated by a variety of (patho)physiological stimuli: 1. Agonists of G-protein coupled 
receptors such as angiotensin II and endothelin, 2. Growth factors such as thrombin and 
vascular endothelial growth factor, 3. Cytokines such as TNF-, 4. Metabolic factors such as 
increased glucose, insulin, non-esterified fatty acids, advanced glycation end products, 5. 
Oxidized lipids, 6. Oscillatory shear stress , and 7. Hypoxia/reoxygenation and nutrient 
deprivation.  
A major mechanism involved in NADPH oxidase activation is the PKC (protein kinase C)-
dependent phosphorylation of the p47phox regulatory subunit and its translocation to the 
membrane heterodimer. TNF- induced endothelial oxidase activation downstream phos-
phorylation of extracellular signal-regulated kinase, involves not only the phosphorylation 
of p47phox, but also its binding to TRAF4 (TNF-receptor associated factor 4) (Li et al., 2005). 
The other mechanism, occurs via the action of Src, EGF receptor transactivation and the 
subsequend activation of PI3- kinase which leads to the robust activation of Rac and an 
enhanced  and prolonged oxidase dependent ROS production. The  activation of the oxidase 
by Rac 1 is therapeutically relevant because Rac 1 activation requires its post-translational 
modification by isoprenylation, a process that is inhibited by -hydroxy-3-methylglutaryl-
CoA reductase inhibitors (statins). 
3. Endothelial cell activation 
Generally, ECs are constantly a target for a wide variety of stimuli which can induce an EC 
response in three different ways: 1) stimulation – a rapid response of resting ECs initiated by 
agonists such as histamine, 2) activation – a slower protein synthesis-dependent response 
mostly initiated by inflammatory cytokines, (these two responses are normal EC functions), 
3) injury - a process occurring by strong stimuli which can induce either endothelial necrosis 
or endothelial dysfunction. 
A large number of distinct pathogens including viruses, bacteria and their products, 
protozoa, anti-EC antibodies, reactive oxygen species, rickettsiae and toxins can be directly 
or indirectly involved in EC activation (Figure 1). ECs can be also a target for angiogenic 
signals in neoplasia, and a major target for an immune reaction directed against alloantigens 
or xenoantigens. Some of them (like viruses) infect ECs, others (viruses, bacteria and their 
products, anti-EC antibodies)  interact with ECs and induce or modify cytokine production. 
EC activation triggered by inflammatory cytokines (e.g. TNF-, IFN-, IL-1) or growth fac-
tors (e.g. angiotensin II) can induce the expression of a functional program related to throm-
bosis and inflammation. Thus, under stronger insults ECs initially acquire a proinflamma-
tory and procoagulant phenotype. Since the ultimate goal of the activated EC is to survive, it 
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leads the cell to add to the constitutively- expressed protective machinery by initiating the 
upregulation of a new set of protective genes, including those for A1 and A20 (Bach et al., 
1997). 
 
 
Fig. 1. Endothelial cell activation 
During activation ECs not only develop a characteristic morphology but also synthesize a 
new surface protein and soluble mediators not present in the resting vascular endothelium. 
Many of these morphologic and functional changes can be induced in cultured ECs by 
purified immune mediators, such as monokines, lymphokines and bacterial LPS. Numerous 
inducible genes involved in endothelial activation, including cell adhesion molecule 1, E-
selectin, tissue factor, interleukin-1 (IL-1), interleukin-6 (IL-6), G-CSF, interleukin-8 (IL-8) 
and c-myc contain elements in their promoter regions that could be recognized by the NF-
κB 1/Rel family of transcription factors. ECs also express an inhibitor of NF-κB, IκB-, and 
can dramaticaly modulate the level of this inhibitor in parallel with the activation process. 
One of the earliest changes in the endothelium activation is an alteration in the glycocalyx 
composition. Glycocalyx contains anchoring proteoglycans (CD44, the syndecan protein 
family) and conecting glycosaminoglycans. The major class of negatively charged polysacc-
harides that contribute to the glycocalyx include heparan sulfate, chondroitin sulfate and the 
nonsulfated hyaluronan. The various combinations of possible sulfation modifications 
within a heparan sulfate chain can give rise to many structurally distinct binding sites for a 
wide rage of different ligands, including chemokines, growth factors, lipoproteins, lipases, 
serine protease inhibitors, thrombomodulin, extracellular SOD and complement factors 
(Weinbaum et al., 2007). The endothelial glycocalyx (Tarbell & Ebong, 2008) markedly 
changes its properties under inflammatory conditions which facilitates rolling adhesion and 
tight adhesion of leucocytes. Cytokines activate proteases either located in glycocalyx or 
secreted by activated ECs and leucocytes which partially degrade the glycocalyx layer and 
thereby provide a mechanism for leucocyte recruitment (Mulivor & Lipowsky, 2004). Also, 
the release of glycocalyx components into the circulation can be considered as a very early 
sign of endothelial activation. So, syndecan 1 and heparan sulfates have been shown to be 
released from the endothelium following stimulation by thrombin or endotoxin (Fitzgerald 
et al., 2000), and circulating glycocalyx components have been explored as a measure of 
endothelial activation in patients with type 2 diabetes and the coronary artery disease 
www.intechopen.com
 
Advances in the Etiology, Pathogenesis and Pathology of Vasculitis 
 
160 
(Bruegger et al., 2009; Wang et al., 2009). During sustained endothelial activation platelets 
and leucocytes bind to the endothelial surface leading to the formation of proinflammatory 
factors such as thrombin and the membrane attached complex which can cause further 
activation of the endothelium and promote the formation of membrane particules so called 
microparticles. Microparticles from ECs, platelets and leucocytes are released into the 
circulation. The interaction between ECs and pericytes is disrapted and pericytes begins to 
produce proteases that damage the endothelial basement membrane. These processes may 
lead to the apoptosis or necrosis of ECs or ECs can be detached and detected in the 
circulation (Haubitz & Woywodt, 2004). 
3.1 Nuclear factor-κB 
NF-κB is a redox sensitive transcription factor associated with rapid-response activation 
mechanisms. It consists of homo- or heterodimeric complexes of members of the Rel family 
of proteins: p50/p105 (NF-κB1, derived from its p105 precursor), p52/100 (NF-κB2 and its 
p100 precursor), p65/RelA, c-Rel and Rel-B. The best characterized form is the heterodimer 
p50/p65. These proteins share a 300 amino acid region known as the Rel homology domain, 
which mediates DNA binding and dimerization. In resting cells, NF-κB binding proteins are 
in an inactive cytosolic form and are complexed to members of a family of inhibitory pro-
teins referred to as IκB (IκB-, IκB-, IκB-, IκB-σ and IκB-ε). IκB- is the best characterized 
inhibitor, which binds to the p65 subunit of NF-κB (Baldwin, 1996). All IκB forms contain 
multiple ankyrin repeats which are involved in interactions with NF-κB. NF-κB can be 
activated by a number of divers agents such as the citokines, IL-1, and TNF-, LPS, oxi-
dative stress, oxidatively modified LDL particles, viral products, advanced glycosylation 
end products and physical forces. These stimuli may activate the NF-κB kinase complex 
through distinct signaling pathways that culminate in the activation of the IκB kinase. In this 
way they induce IκB- release from the p65 subunit after its phosphorilation. After 
phosphorilation IκB is ubiquitinated and targeted for degradation via the nonlysosomal 
ATP-dependent proteosome pathway  followed by a rapid loss of this protein. Alterations in 
IκB- at the levels Ser32 and Ser36, which prevent its phosphorilation and degradation, lead 
to  blocking IκB- ubiquitination and subsequent degradation (Brown et al., 1995). A 
removal of IκB- exposes a nuclear localisation sequence in NF-κB which is then able to 
translocate to the nucleus, bind to a specific DNA sequence (5’-GGGRNNYYCC-3’) and 
activate NF-κB dependent genes. 
IκB- is rapidly resinthesized after the loss, suggesting an autoregulatory mechanism for 
NF-κB regulation in the endothelium (Thurberg & Collins, 1998). When the IκB- pool is 
replenished, IκB- translocates to the nucleus and displaces the transactivating form of NF-
κB from promotor elements. The NF-κB/IκB- complex is then transported back to the 
cytoplasm in the inactive form. Further, the genes that code for p65, p105 and IκB- are 
highly inducible in ECs in response to the stimuli that activate NF-κB. The promoter  of the 
IκB--gene contains  κB binding sites. p65 stimulates IκB- gene expression (Baldwin, 1996)    
and p65 stabilises IκB- protein indicating that p65 and IκB- have been directly linked in 
an autoregulatory loop. The NF-κB/IκB- autoregulatory system may ensure that the 
induction of NF-κB is transient, and that the activated cell returns to a quiescent state. It 
allows a continuous maintenance of the cytoplasmatic reservoirs of NF-κB complexes for 
stimulation in an acute response, and also prepares the EC to return NF-κB to its uninduced 
condition. 
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The rapid cytokine-induced activation of NF-κB in ECs is probably similar to that seen in 
other cell types. However, the recovery kinetics of the NF-κB/IκB- response in the 
endothelium may be different. The NF-κB remains activated and IκB- levels remain below 
basal levels for long periods of time than seen in cells programmed for rapid responses, such 
as macrophages (Read et al., 1994). It is possible that cytokines released by activated ECs 
result in an autocrine activation of NF-κB and continued degradation of IκB-. Such prolon-
ged endothelial activation may play a role in recruiting circulating cells to the sites of 
ongoing inflammatory (artherosclerosis) (Ahn et al., 2006; Brand et al., 1997) or immune 
processes (autoimmune diseases). The NF-κB activation can be blocked by sodium salicylate 
and aspirin (Kopp & Ghosh, 1994). 
However, in addition to the proinflammatory genes, activated NF-κB may induce a set of 
protective genes, including antiapoptotic genes that may limit the activation process and 
thereby regulate the respons to injury. The protective genes include IκB- and hemoxyge-
nase, as well as the antiapoptotic genes A20, Bcl-2, and Bcl-XL. Besides the antiapoptotic 
activity, the antiapoptotic genes also inhibit the activation of NF-κB in ECs and thus block 
the induction of the proinflammatory genes (Bach et al., 1997). Some stimuli, such as laminar 
shear stress, upregulate genes for manganese superoxide dismutase, cyclooxygenase-2 and 
endothelial specific nitric oxide synthase. Since this set of genes has antioxidant, antithrom-
botic and antiadhesive properties, they can be also recognised as “protective”. When the 
protective effect is not adequate, ECs undergo apoptosis.  
To maintain an antiinflammatory and anticoagulant state the endothelium also requires 
environmental cues. Laminar shear stress is a key contributor to the integrity of ECs through 
the inhibition of apoptosis. Shear stress also activates specific transcription factors, such as 
kruppel-like factor 2 and nuclear factor erythroid 2-related factor 2 (Dekker et al., 2002; 
Chen et al., 2003). These transcription factors regulate about 70% of the genes responsive to 
shear stress, including those that encode typical protective endothelial factors such as eNOS, 
thrombomodulin and antioxidant enzymes, but at the same time they down regulate genes 
that encode procoagulant factors such as plasminogen activator inhibitor 1, IL-8 and the 
tissue factor (Fledderus et al., 2008). It seems that kruppel-like factor 2 can be directly regu-
lated by shear stress, while the nuclear factor erythroid 2-related factor 2 is released from its 
inhibitor, kelch-like ECH associated protein 1, through the generation of ROS, which 
suggests that it functions as a defense mechanism against antioxidants (Kraft et al., 2004). 
However, in the stabilisation of the endothelial phenotype a key role belongs to the recipro-
cal interaction of stromal or epithelial cells with the endothelium. ECs have direct physical 
contact with pericytes and vascular smooth muscle cells through myoendothelial junctions. 
Pericytes send signals to the endothelium through number of factors including hydrogen 
sulfide, all isoforms of VEGF (vascular endothelial growth factor), sphingosine-1-phosphate, 
platelet-derived growth factor, basic fibroblast growth factor and angiopoietin I (Gaengel et 
al., 2009; Diaz-Flores et al., 2009). Angiopoietin I is best known to stabilize the endothelium 
and to maintain its quiescent state. If the signaling between angiopoietin I and the ECs is 
interrupted ECs sprout and migrate; this results in neoangiogenesis (Chen & Stinnett, 2008). 
3.1.1 Regulation of NF-κB dependent gene expression 
The activation of the pleiotropic mediator NF-κB in ECs could coordinate the expression of 
numerous endothelial products which are important in endothelial activation including 
some cell surface adhesion proteins, cytokines, growth factors, NADPH oxidase, NOS, 
prostanoides, acute phase reactants and components of the coagulation system. They may 
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be multiple phosphorylation events which play a key role in NF-κB activation. Some of the 
cytosolic NF-κB/IκB- is associated with the catalitic subunit of the cAMP-dependent pro-
tein kinase, PKAc, in an inactive state. The signal-induced degradation of IκB- leads to the 
activation of PKAc which phosphorilates the p65 subunit of NF-κB on Ser276. This causes a 
conformational change which unmasks the CREB binding protein (cAMP-responsive 
binding protein) interacting domain on p65. Once CREB interacting domain on p65 is 
unmasked, NF-κB interaction with a coactivator is enhanced and NF-κB can enter the 
nucleus (Zhong et al., 1997). Lysophosphatidylcholine, one of the active molecules present 
in oxLDL, has been shown to activate NF-κB in primary cultured ECs via a PKC dependent 
pathway. ECs can also be shown to be responsive to oxLDL in vivo. When unmodified 
human LDL particles are injected into a rat model, they are localized in the arterial wall 
were they undergo oxidative modification which is accompanied by an increase in 
endothelial NF-κB activation and expression of NF-κB dependent genes (Calara et al., 1998). 
In the nucleus, the p65 subunit can be phosphoregulated by the components of the p38 and 
ERK MAP kinase signal patways (Berghe et al., 1998).  
4. Endothelial cells and inflammation 
ECs actively participate in the inflammatory process acting as both a target and a responder 
to a variety of stimuli. Whatever the initial stimuli (mechanical, chemical, infectious or 
immunological) they activate ECs. There are two stages of EC activation; the first-EC 
activation type I which does not require de novo protein synthesis or gene upregulation, 
occurs rapidly and it is followed by the retraction of ECs, expression of P selectin and 
release of von Willebrand factor. The second response, EC activation type II, requires time 
for the stimulating agent to cause an effect via gene transcription and protein synthesis. A 
stimulating agent acting on the EC surface causes the expression of many genes via the 
activation of NF-κB (Baldwin, 1996). EC activation is a graded rather than an all response. 
For example, changes in EC integrity range from simple increases in local permeability to 
major EC contraction, exposing large areas of subendothelium. Activation may proceed as 
an acute response or as a chronic EC activation such as in atherosclerosis and in vascular 
diabetic complications. Ligands of RAGE (the receptor for advanced glycation end products) 
mediate continuous NF-κB activation which results in persistent endothelial tissue factor 
induction. The activation may occur locally, as in transplant rejection, or systematically, as 
in septicaemia and the systemic inflammatory response. 
Generaly, EC activation is associated with five core changes including the loss of vascular 
integrity, expression of leucocyte adhesion molecules, change in phenotype from antithrom-
botic to prothrombotic, cytokine production and upregulation of HLA molecules. The loss of 
vascular integrity can expose subendothelium and cause the efflux of fluids from the 
intravascular space.  
The first step in EC activation, independently on the initial stimuli, involves inflammatory 
cytokines mostly TNF-, IL-1 and IFN- (Steiner et al., 1997). They stimulate ECs to produce 
monocyte chemotactic protein-1 (MCP-1). Vascular cells produce three more chemokines 
including IP-10, MIG, I-TAC, when exposed to the inflammatory mediator IFN-, a molecule 
produced by activated T cells and perheps macrophages. MCP-1 recruits and activates 
immune and inflammatory cells which produce inflammatory cytokines and induce the 
expression of adhesion molecules. The upregulation of surface glycoproteins such as 
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endothelial leucocyte adhesion molecule-1 (ELAM-1, also known as E-selectin), intercellular 
adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and MHC 
molecules allows leucocytes to adhere to the endothelium and then move into tissues. 
 
 
Fig. 2. Endothelial cells and inflammation 
Tissue infiltration by circulating leucocytes is a four-step process involving low affinity 
attachment, roling on the endothelium, high affinity attachment to the endothelium, follo-
wed by transmigration across the ECs lining blood vessel walls. These processes are medi-
ated by adhesion molecules. Four distinct families of adhesion molecules including cadhe-
rins, immunoglobulin superfamily members, selectins and integrins are involved in vascular 
cell-cell adhesion. These molecules are requred four: 1. The formation of the junctional 
complexes that enable the assembly of ECs into functional vascular networks; 2. They 
mediate the leucocyte-endothelial adhesive interactions involved in the trafficking of leuco-
cytes out of the circulation but the set of adhesion molecules expressed by ECs depends on 
the stimuli (Cook-Mills & Deem, 2005) while the specificity of the adhesion molecules 
regulates the specificity of leucocyte homing to tissues; and 3. They contribute to contacts 
between pericytes and the endothelium  that are important to the regulation of EC prolife-
ration, addressin interaction, rolling which can also be mediated by the interaction of 
leucocyte 41-integrin and VCAM-1/CD106. A transitory contact of leucocytes with the 
endothelium or their rolling are mediated by low-affinity receptors, selectins and 
addressins.  
The binding of selectins on leucocytes stimulates “outside-in” signals in leucocytes, increa-
sing the affinity of the integrin family of receptors, which then bind to EC adhesion mole-
cules such as ICAM-1/CD54 and VCAM-1. The regulation of the expression of the adhesion 
molecules occurs by negative control as well as at the level of gene transcription. For 
example, NO can reduce leucocyte adhesion to arteries and can counteract the induction of 
VCAM-1 expression by ECs stimulated by inflammatory cytokines such as IL-1 or TNF-. 
At the transcriptional level, NO inhibits VCAM-1 gene expression in ECs by interfering with 
the NF-κB signaling pathway via a non-cyclic GMP-mediated mechanism (Peng et al., 1995). 
Instead, NO inhibits NF-κB by inducing its inhibitor IκB-. Thus, NO acts as an anti-infla-
mmatory mediator. Leucocyte integrin affinity is also rapidly increased by “inside-out” 
signals from leucocyte chemokine receptors triggered by chemokines expressed on the sur-
face of ECs. When leucocyte integrin affinity is increased, leucocyte roling is arrested. 
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More sustained sticking of leucocyte to the endothelium is mediated by VCAM-1 which 
binds to the cognate ligand VLA-4 (very late adhesion molecule-4) that is expressed by the 
very types of leucocytes recruited to the intima: monocytes and lymphocytes, respectively. 
Once adherent, the  leucocytes enter the vascular wall. Leucocyte migration from the blood 
into tissues is vital for  immune surveillance and inflammation. Leucocytes can stimulate 
“outside-in” signal transduction in ECs and some of these signals can cause localized 
alterations in EC junctions. 
At the sites of inflammation, activated antigen specific lymphocytes are the first to migrate 
across activated endothelium expressing adhesiom molecules. During the leucocyte-EC 
interaction, the EC promotes the migration of leucocytes or removes leucocytes that are in 
the early stages of apoptosis. Leucocytes can be found within the vacuolar structures of ECs  
only when ECs phagocytose apoptotic leucocytes. This function of ECs may be a mechanism 
by which the endothelium is protected from the localised vascular damage which would 
occur if apoptotic leucocytes were to undergo necrosis. Thus, we can say that ECs modulate 
leucocyte migration by promoting leucocyte migration or removing leucocytes undergoing 
apoptosis. 
While lymphocytes migrate acros activated endothelium neutrophils and monocytes migra-
te between ECs (Mamdouh et al., 2003). It has been shown that neutrophils roll across the 
luminal surface of human umbilical vein ECs to bicellular and tricellular EC junctions. In 
response to peptid N-formyl-methionyl-leucyl-phenylalanine neutrophils migrate through a 
pore in nonactivated cutaneous ECs. Adhesion molecule signals result in alterations in the 
function of cell junction proteins and/or contractile forces in the EC, thereby opening an EC 
junction and permitting leucocyte migration into the tissue. During neutrophil and mono-
cyte migration, localized EC retraction of lateral junctions occurs at the site of leucocyte 
migration showing that contractile forces in ECs have an active role in leucocyte migration. 
4.1 Selectins 
Three selectins have been characterized and named according to their cell of original disco-
very: P-selectin (platelet selectin), E-selectin (EC selectin) and L-selectin (leucocyte selectin). 
These are glycosylated proteins, which share several structural features and support leuko-
cyte-EC and leukocyte-platelet adhesion. L-selectin is constitutively expressed by most 
leucocytes, but not by other cell-types. The ECs of high endothelial venules of lymph nodes 
constitutively express ligand for L-selectin (lymphocyte homing receptors) and L-selectin 
plays a central role in the normal recirculation of lymphocytes. ECs from other vascular 
beds also support L-selectin-mediated adhesion after the exposure to cytokines. P-selectin, 
which is expressed by ECs and platelets, is stored in intracellular granules and mobilized to 
the surface upon cell activation where it supports the adhesion of granulocytes, monocytes 
and some lymphocyte subsets. E-selectin is expressed by cytokine-activated ECs and 
supports adhesion of granulocytes, monocytes, some memory T-lymphocytes and natural 
killer cells (Bevilacqua & Nelson, 1993; Brady, 1994). 
4.2 Integrins 
Selectin - mediated adhesion facilitates the immobilization of phagocytes by the interaction 
of phagocyte integrins with immunoglobulin-like molecules on the endothelium. Integrins 
are heterodimeric glycoproteins composed of non-covalently associated  and  subunits. 
Integrins mediate diverse cell-cell and cell-matrix interactions. The most important integrins 
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in leukocyte-endothelial adhesion include the very late activation antigen-4 1 integrin 
(VLA-4) and the CD11/CD18 -2 integrins. VLA-4 is constitutively expressed by 
lymphocytes, monocytes, basophiles and eosinophils, but not neutrophils. This protein is a 
ligand for the inducible vascular cell adhesion molecule-1 (VCAM-1) and also mediates cell 
attachment to fibronectin and possibly other matrix components. -2 integrins include three 
well characterized members: CD11a/CD18 (LFA-1, Lymphocyte function-associated 
antigen-1), CD11b/CD18 (Mac-1) and CD11c/CD18 where CD11 and CD18 are the  and  
subunits, respectively. LFA-1 is found on all T- cells and also on B-cells, macrophages and 
neutrophils. CD11 subunits are encoded by distinct genes in a cluster on chromosome 16, 
while CD18 is encoded by a single gene on chromosome 21. CD18 contains a short 
cytoplasmic tail which has several potential phosphoregulation sites, a highly conserved 
transmembrane domain and a long extracellular region which contains a conserved cystein-
rich region that is necessary for surface expression (Brady, 1994). The major ligands for 
CD11a/CD18 are the intercellular adhesion molecules-1 and 2 (ICAM-1 and ICAM-2). 
ICAM-1 is also a ligand for CD11b/CD18 which supports phagocyte adhesion to cellular 
and acellular substrates by ICAM-1 independent mechanisms. Other ligands for 
CD11b/CD18 include fibrinogen, clotting factors and complement fragments (C3bi). 
4.3 Immunoglobulin-like molecules  
4.3.1 Platelet-EC adhesion molecule-1 (PECAM-1) 
PECAM-1 adhesion at the lateral borders of nonactivated ECs participates in the formation 
of EC junctions and my be a critical regulator of phagocyte diapedesis between ECs. 
PECAM-1 also mediates the binding with PECAM-1 on leucocytes. Although there is 
PECAM-1 independent models of lymphocyte, neutrophil and monocyte migration  anti-
PECAM-1 antibodies can block monocyte diapedesis across TNF-α or IL-1-activated ECs 
(Schenkel et al., 2002). PECAM-1 can activate signals that increase leukocyte adhesion 
(Chiba et al., 1999). Also, PECAM-1 has been shown to recycle between the cell membrane 
and a cytoplasmic compartment juxtaposed to the membrane. PECAM-1 is recruited to the 
EC surface at the sites of monocyte transmigration (Mamdouh et al., 2003). A treatment of 
nonactivated cells with an inducer of oxidative stress increases PECAM-1 phosphorylation 
followed by an increase in leukocyte migration. PECAM-1 phosphorylation is regulated by 
ser/thr phosphatases which can be blocked with anti-PECAM-1 antibodies, antioxidants or 
inhibitors of PKC, Ras and glutathione synthesis (Rattan et al., 1997). The homophilic 
adhesion of PECAM-1 stimulates its binding to several intracellular proteins involved in 
signaling including Src homology containing phosphatase, phospholipase C- and Pi-3k 
(Jackson et al., 1997; Pellegatta et al., 1998; Pumphrey et al., 1999). Phosphorylated PECAM-1 
can be linked to the cytoskeletal catenins thereby limiting their translocation to the nucleus 
thus modulating gene expression. 
PECAM-1 localization in ECs is modulated by cytokines. The simultaneous treatment with 
TNF-α and IFN- moves PECAM-1 out of lateral junctions without inhibiting the ability of 
monocytes to migrate across these ECs under laminar flow conditions suggesting that 
sufficient PECAM-1 is still available for migration (Shaw et al., 2001). 
4.3.2 Intercellular adhesion molecule-1 (ICAM-1) 
ICAM-1 is a glycoprotein which contains five tandem immunoglobulin domains. It is 
constituvely expressed on many cell types but can be increased on endothelium by 
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inflammatory mediators (Roebuck & Finnegan, 1999). The first and third immunoglobulin-
like domain of ICAM-1 bind to the counter-receptors of LFA-1 and membrane-activated 
complex-1 (CD11b/CD18) respectively, on leucocytes, but it can also bind to fibrinogen on 
lymphocytes (Dupperay et al., 1997). A chelation of intracellular calcium or the inhibition of 
PKC in IFN- treated brain EC lines blocks ICAM-1 dependent lymphocyte migration 
without affecting lymphocyte adhesion (Etienne-Manneville et al., 2000). ICAM-1 stimulates 
ECs to produce chemokines through the activation of ERK1 and ERK2 (Sano et al., 1998) 
suggesting that ICAM-1 induces EC signals that are required for lymphocyte migration. 
ICAM-1 signals can also regulate the EC actin cytoskeletion. The antibody cross-linking of 
ICAM-1 on TNF-α-activated pulmonary microvascular ECs activates xanthine oxidase and 
p38 MAPK (Wang & Doerschuk, 2001), resulting in actin rearrangement, and can also indu-
ce phosphorylation of another cytoskeleton protein ezrin. ICAM-1 associates with the cyto-
skeletal protein ezrin through phosphatidylinositol 4,5-biphosphate (Heiska et al., 1998). 
Homotypic and heterotypic lymphocyte adhesion mediated by the interaction of ICAM-1 
and CD11a/CD18 facilitates other important lymphocyte functions including antigen 
recognition, lymphocyte co-stimulation and cytotoxicity. 
4.3.3 Vascular cell adhesion molecule-1 (VCAM-1) 
VCAM-1 is a glycoprotein containing seven immunoglobulin-like domains which predomi-
nates in ECs. A second form of VCAM-1, consisting of six immunoglobulin-like domains, is 
produced in some tissues by alternate splicing. VCAM-1 is constitutively expressed at low 
levels by ECs and can be induced on these and other cell-types by cytokines. VCAM-1 
supports the adhesion of eosinophils, basophils, monocytes and lymphocytes but not 
neutrophils, through the interaction with VLA-4. The binding of lymphocytes to VCAM-1 
stimulates localized EC-shape changes and the “opening of a narrow passage way” through 
which leucocytes can migrate (Cook-Mills & Deem, 2005; Matheny et al., 2000). Lymphocyte 
binding to VCAM-1 activates ECs NADPH oxidase for the generation of ROS in ECs which 
constitutively express VCAM-1 and the MCP-1. The VCAM-1-mediated activation of 
NADPH oxidase is dependent on calcium flux and the small molecular weight G protein 
Rac1. Rac1 is involved in the assembly of the active NAPH oxidase complex in ECs such as 
in neutrophils (Dorseuil et al., 1995).  
ICAM-1 and PECAM-1 do not activate EC NADPH oxidase. The VCAM-1-stimulated EC 
NADPH oxidase activity is required for VCAM-1-dependent lymphocyte migration because 
the inhibition of EC NADPH oxidase blocks MCP-1 stimulated, VCAM-1 dependent 
lymphocyte migration without altering lymphocyte adhesion. ROS scavengers inhibit 
VCAM-1 dependent lymphocyte migration while VCAM-1 dependent lymphocyte migrati-
on is not blocked by the inhibition of ROS-generating enzymes NOS, xanthine oxidase or 
cytochrome p450 on ECs (Matheny et al., 2000). 
Lymphocyte binding to VCAM-1 induces a low concentration of hydrogen peroxide (1mol) 
production in ECs (Tudor et al., 2001) much lower than those (50-200 mol) produced  by 
neutrophils and macrophages for the destruction of pathogens (DeLeo & Quinn, 1996) or 
released in some diseases (Thannickal & Fanburg, 2000). Low levels of ROS induce rapid, 
transient and reversible signals. This is important, since once a leucocytes reach an EC 
junction, the process of transmigration occurs within a couple of minutes. Another function 
of the ROS produced during VCAM-1-dependent lymphocyte migration is the activation 
(within minutes) of matrix metalloproteinases (MMPs) associated with ECs or IL-4 activated 
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ones. The EC-derived hydrogen peroxide also activates lymphocyte-associated MMPs but 2-
5 hours later. These results show that the ECs-associated rather than the lymphocyte-
associated MMPs are required for VCAM-1-dependent lymphocyte migration across 
VCAM-1-expressing ECs (Deem & Cook-Mills, 2004). 
Hydrogen peroxide produced by VCAM-1 stimulation has a direct, rapid effect on EC-
associated MMPs. ROS activate purified MMPs by oxidizing the cysteine in the propeptide 
arm opening the arm and exposing the MMP active site (Murphy et al., 1994) which stimu-
late the autocatalytic removal of the arm, forming an active MMP (Van Wart & Birkedal-
Hansen, 1990). Contrary to EC-associated MMPs, hydrogen peroxide indirectly activates 
lymphocyte-associated MMPs through the down-regulation of the expression of the high 
levels of tissue inhibitors of MMPs (TIMPs) on lymphocytes (Deem & Cook-Mills, 2004) 
which takes several hours indicating that lymphocyte MMPs are likely involved in the 
leukocyte migration through the extravascular tissue (Cook-Mills & Deem, 2005). 
MMPs associated with ECs are more important than secreted MMPs during lymphocyte 
migration. Among MMPs the EC-associated MMP-2 and MMP-9 are likely to degrade 
matrix and EC junction molecules at the site of transmigration (Herren et al., 1998). 
5. Endothelial cells and vasculitis 
5.1 Vasculitis triggered by infectious agents 
Vasculitis can be a primary disease, that is not associated with another cause. Or, it may be a 
complication of some other diseases such as infections, malignancy, reactions to certain 
medications (Zhang et al., 2010), a complication after an organ transplant, a connective 
tissue disease or other causes. 
The participation of ECs in the pathogenesis of vascular inflammation is complex. On one 
hand, the vascular endothelium may be the target for injury. On the other hand, ECs may 
actively participate in amplifying and maintaining the inflammatory process. The role of 
ECs seems to be more prominent in small vessel vasculitis, such as hypersensitivity vascu-
litis and vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA). In larger 
vessel vasculitis, ECs are the crucial protagonist of the vascular response to inflammation 
which leads to the amplification of the inflammatory response, vessel remodeling and 
repair, and eventually, vessel occlusion, which is the source of some of the most severe 
complications in patients with systemic vasculitis. 
Although most of the infection related vasculitides are immune-complex-mediated (hepati-
tis B virus-related polyarteritis nodosa, and hepatitis C virus associated cryoglobulinemia) 
some pathogens are able to directly infect the ECs. Primary vasculitis can be induced by 
several pathogenic mechanisms. The direct infection of ECs include: bacterial vasculitis 
(naisserial), spirochetal vasculitis (syphilitic), mycobacterial vasculitis (tuberculous), rickett-
sial vasculitis (Rocky Mountain spotted fever), fungal vasculitis (aspergillosis) and viral 
vasculitis (herpes virus, herpes zoster) (Heeringa et al., 2004). Rickettsiae and herpes virus 
family members, particularly cytomegalovirus are the best documented (Mandell & 
Calabrese, 1998). Serious infections by these agents frequently include vasculitis lesions. The 
proliferation of the rickettsial organism in small-vessel walls elicits an inflammatory 
response that results in focal vascular inflammation, often with necrosis and hemorrhage. 
However most forms of vasculitis do not appear to be caused by the direct infection of 
vessel walls by pathogens.  
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5.2 Immune complex-mediated vasculitis 
Noninfection immunologic mechanisms that cause vasculitis include cell-mediated 
inflammation, immune complex-mediated inflammation and inflammation induced by 
ANCA. Immune complex-mediated vasculitis include: cryoglobulinemic vasculitis, Henoch-
Schonlein purpura, serum sickness vasculitis, lupus vasculitis, infection-induced immune 
complex vasculitis (hepatitis virus), some drug-induced vasculitis (sulfonamide-induced 
vasculitis), some paraneoplastic vasculitis, and Goodpasture’s syndrome (mediated by anti 
GMB antibodies) (Heeringa at al., 2004). 
In immune complex-mediated vasculitis, EC morphology is altered and the luminal endo-
thelium may be destroyed. Complement-mediated lysis as well as neutrophil-mediated EC 
damage are the main mechanisms of endothelium cell injury in these processes (Cid, 2002). 
The membrane attack complex C5b-9, final product of the complement activation cascade, 
has been detected in the necrotizing vasculitis of the polyarteritis nodose type (Kissel et al., 
1989). 
5.3 ANCA-mediated vasculitis 
Wegener’s granulomatosis, microscopic polyangitis, and Churg-Strauss syndrome are the 
major forms of small-vessel vasculitis that are strongly associated with ANCA (Heeringa et 
al., 2004). ANCA vasculitis may be induced by some drugs, such as thiouracil. There are two 
clinically important forms: cytoplasmatic ANCA (cANCA) and perinuclear ANCA 
(pANCA). ANCA are autoantibodies that are directed against constituents of the primary 
granules of neutrophils and the peroxidase positive lysosomes of monocytes. The primary 
antigenic targets for ANCA are proteinase-3 (PR3), a 29kD neutral serin protease, and 
myeloperoxidase (MPO), a 140kD enzyme involved in the generation of ROS (Falk & 
Jennette, 1988; Jennette et al., 1990). ANCA recognizes MPO or PR3 translocated to the 
neutrophil membrane on TNF-α or interleukin-8 (IL-8) primed neutrophils (Flint et al., 2010) 
or may bind to Fc receptors through their Fc portion. Both interactions, specific and Fc-
mediated appear to be functionally relevant (Falk et al., 1990; Porges et al., 1994). ANCA 
immunoglobulin G can activate neutrophils and monocytes. ANCA binding to neutrophils 
may stimulate or amplify many neutrophil functions including respiratory bursts which 
generate ROS, degranulation and protease release (Falk et al., 1990), NO production (Tse et 
al., 2001), and chemotactic activity. ANCA binding also stimulates integrin expression and 
integrin-mediated homotypic adhesion and adhesion to ECs (Radford et al., 2000). 
Homotypic interactions mediated by neutrophil integrins are required for enhanced TNF-α 
induced neutrophil activation by ANCA. ANCA-stimulated neutrophil function results in 
an augmentation of neutrophil-mediated EC injury by inducing EC detachment and lyse of 
ECs previously damaged by other mediators. Further, in an inflammatory microenvi-
ronment, enzymes released by activated neutrophils, including MPO and PR3, may induce 
EC apoptosis (Yang et al., 2001). 
ANCA-mediated monocyte and neutrophil activation has also been shown to induce the 
expression and secretion of proinflammatory cytokines (IL-1, IL-6, IL-8, TNF- α), chemoki-
nes (MCP-1) and prostanoids (Cid, 2002; Cid et al., 2004). Such mediators may contribute to 
the amplification and propagation of the inflammatory process. 
The detection of ANCA is an important diagnostic and prognostic marker. Testing of ANCA 
is indicated in patients with evidence for the ANCA disease such as severe pulmonary 
hemorrhage, especially if accompanied by evidence for glomerulonephritis, peripheral 
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neuropathy, purpura, hemorrhagic sinusitis or other manifestations of small-vessel 
vasculitis. 
However, the use of ANCA as a marker of the disease and its activity show a number of 
limitations such as the occurrence of high ANCA titers with no disease activity, or ANCA 
presence in non-vasculitis disorders, such as endocarditis (Choi et al., 2000) or tuberculosis 
(Flores-Suarez et al., 2003). In addition, circulating ECs have been used as markers in a 
variety of vascular disorders (Dignat-George & Sampol, 2000) and also their use is demon-
strated in ANCA-associated small-vessel vasculitis (Haubitz and Woywodt, 2004). Recently 
it has been documented that an increase risk for relapse appears to be related to the presence 
of anti-PR3 antibody seropositivity. 
5.4 Anti endothelial cell antibodies 
Circulating anti-EC antibodies have been detected in several vasculitides including 
Wegener’s granulomatosis, microscopic polyangitis, Kawasaki diseases, thromboangiitis 
obliterans, Bechet’s disease and Takayasu’s arthritis (Praprotnik et al., 2001). It seems that a 
large, highly heterogeneous group of antigens can be recognized by anti-EC antibodies. 
Some anti-endothelial antibodies, such as those detected in Kawasaki disease, recognize 
cytokine-inducible molecules, while others, such as those detected in Wagener’s 
granulomatosis and microscopic polyangitis, recognize constitutive EC antigens (Del Papa 
et al., 1996). 
Studies in vitro have shown that some anti-EC antibodies may trigger complement 
activation or anti-body-dependent cellular cytotoxicity. These mechanisms might contribute 
to EC damage in systemic vasculitis. That alloantigens can activate ECs is well recognized 
within transplantation where HLA-specific antibodies can activate EC NF-κB (Savage & 
Williams, 2007; Smith et al., 2000). EC antibodies arise most probably as a secondary event 
to endothelial injury. Initial endothelial injury may result from pathogenic processes that 
may be unleashed during the development of the vasculitis process itself (for example, by 
proteolytic enzymes released from neutrophils after their inappropriate activation by 
ANCA). It is also likely that sequestered viral infections, such as cytomegalo-virus that can 
replicate within ECs, may become relatively more activated during the development of an 
autoimmune response and particularly after the introduction of immnosuppression. That 
cytomegalovirus can induce anti-EC antibodies is recognized (Toyoda et al., 1999). The 
binding of anti-EC antibodies to EC in vitro elicits a calcium-flux, the secretion of the chemo-
kines MCP-1 and GCP-2 (but not IL-8 or GRO-), and the upregulation of the ligands MHC-
class I related antigen A (MICA) and vascular adhesion protein-1 (VAP-1). Signal trans-
duction via the SAPK/JNK pathway appears to be important in the increased expression of 
MCP-1, GCP-2 and MICA. In addition, anti-EC antibodies also activate NF-κB. However, it 
has been demonstrated that anti-EC antibodies have an ability to induce EC apoptosis via 
the recognition of Hsp60 (Jamin et al., 2005). Once present, anti EC antibodies have the 
potential to inhibit potent antiinflammatory mechanisms (Nara et al., 2006). 
5.5 The endothelial cell as an inflammation amplifier 
ECs are able to amplify the inflammatory response by three main mechanisms: adhesion 
molecule expression, cytokine production and angiogenesis. Most of the primary immuno-
pathogenic mechanisms playing a role in the pathogenesis of blood vessel inflammation in 
vasculitis include adhesion molecule expression and function (Cid et al., 2002). The studies 
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in vitro show that complement activation products induce adhesion molecule expression by 
cultured ECs. C1q induces E-selectin, ICAM-1 and VCAM-1 (Del Papa et al., 1996) and C5a 
can upregulate P-selectin expression (Foreman et al., 1994). Immune complex and comple-
ment-mediated vessel damage in vivo require adhesion molecule expression and function. 
Also, ANCA binding to EC membrane-associated PR3 or related epitopes may induce E-
selectin and VCAM-1 expression by ECs. PR3 released by neutrophils in the vicinity of ECs 
may induce EC ICAM-1 expression. Anti-EC antibody binding to ECs also induces endothe-
lial adhesion molecule expression (Cid, 2002). The main inducers of endothelial adhesion 
molecules are the cytokines IL-1, TNF- and IFN- which are produced by activated 
lymphocytes and macrophages in an vasculitis area (Raines & Ferri, 2005). 
The expression of inducible adhesion molecules E-selectin and VCAM-1 by ECs as well as 
the upregulated constitutive expression of ICAM-1 were detected in patients with cutaneous 
leucocytoclastic vasculitis, Kawasaki disease, classical polyarteritis nodosa and gian-cell 
arteritis (Cid et al., 2000). In Wegener’s granulomatosis, microscopic polyangitis and ANCA 
associated glomerulonephritis VCAM-1 and ICAM-1 expression were observed at the glo-
merular tuft as well as in tubular epithelial cells and peritubular capillaries (Rastaldi et al., 
1996).  
In small vessel vasculitis, endothelial adhesion molecule expression occurs in luminal 
endothelium (Sais et al., 1997). In medium-sized vasculitis, the luminal endothelium only 
expresses constitutive or inducible adhesion molecules at early stages. As the inflammatory 
process proceeds, the luminal endothelium is damaged and the vascular lumen is occluded. 
Then, endothelial adhesion molecules are expressed by adventitial neovessels (Coll-Vinent 
et al., 1998). In sclerotic glomeruli of kidney ANCA-associated vasculitis glomerular expre-
ssion of ICAM-1 and VCAM-1 declines (Patey et al., 1996). In large-vessel vasculitis, adhe-
sion molecule expression occurs in neovessels at the adventitia and at the intima/media 
junction. These observations suggest that infiltrating leucocytes penetrate the vessel wall 
through the adventitial vasa vasorum and neovessels in large- and medium-sized vessels. 
In an inflammatory setting ECs have the potential to produce a variety of cytokines, 
chemokines and growth factors. In vasculitides a stimulation of ECs arises by ANCA 
binding, some anti-EC antibodies and cytokines released by infiltrating cells. By IL-1 and 
IL-6 production ECs contribute to the systemic acute phase in many systemic vasculitides. 
Colony-stimulating factors produced by ECs prolong the half-life of infiltrating leucocytes, 
while chemokines (IL-8, RANTES, Gro and SLC) selectively attract leucocyte subpopu-
lations which bear specific receptors contributing to tissue targeting and amplifying vessel 
inflammation. 
6. Conclusion 
The endothelium has long been considered a passive physical barrier that only separates 
blood from tissues. Currently, it is clear that the endothelium is one of the most active 
organs which regulates many physiological functions and helps to coordinate functions of 
differentiated tissues in a way that meets the requirements of the organism as a whole. It has 
also emerged that ECs are the key immuno-reactive cells involved in host defence and 
inflammation. These cells both produce and react to a wide variety of mediators including 
cytokines, growth factors, adhesion molecules, vasoactive substances and chemokines, with 
effects on various cells. Prolonged or exaggerated endothelial activation leads to dysfuncti-
on (an early predclinical event of vascular disease) that is regulated by stromal cells and that 
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can drive the vasculitis process with leucocyte recruitment, thrombosis and platelet 
plugging. Such local vascular inflammation has distant effects on the vascular endothelium 
leading to systemic endothelial dysfunction. Besides a whole panel of inflammatory markers 
used to monitor disease activity in systemic vasculitis circulating endothelial cells seem to 
be a promising new marker of this systemic disorder.  
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